![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Voyager program - Wikipedia
The Voyager program is an American scientific program that employs two interstellar probes, Voyager 1 and Voyager 2. They were launched in 1977 to take advantage of a favorable …
Voyager Program - NASA
February’s Night Sky Notes: How Can You Help Curb Light Pollution?
Where are Voyager 1 and Voyager 2 Now? - Science@NASA
2024年3月10日 · Both Voyager 1 and Voyager 2 have reached interstellar space and each continue their unique journey deeper into the cosmos. This near real-time 3D data …
Mission Overview - NASA Science
2024年11月6日 · The Voyager spacecraft are the third and fourth human spacecraft to fly beyond all the planets in our solar system. Pioneers 10 and 11 preceded Voyager in outstripping the …
NASA’s Voyager Will Do More Science With New Power Strategy
2023年4月26日 · The plan will keep Voyager 2’s science instruments turned on a few years longer than previously anticipated, enabling yet more revelations from interstellar space. Launched in …
Voyager - NASA Science
2024年12月9日 · After completing the first in-depth reconnaissance of the outer planets, the twin Voyagers are on a new mission to chart the edge of interstellar space. The contents of the …
The Voyager missions - The Planetary Society
What are the Voyager missions? The Voyager program consists of two spacecraft: Voyager 1 and Voyager 2. Voyager 2 was actually launched first, in August 1977, but Voyager 1 was sent on …
Voyager program - Simple English Wikipedia, the free …
The Voyager program is a space exploration program of the United States ' NASA agency. It consists of a pair of unmanned scientific probes, Voyager 1 and Voyager 2. They were …
Voyager, NASA’s Longest-Lived Mission, Logs 45 Years in Space
2022年8月17日 · Launched in 1977, the twin Voyager probes are NASA’s longest-operating mission and the only spacecraft ever to explore interstellar space.
Voyager Provides Update on SOD1 ALS Gene Therapy Program
4 天之前 · The decision on the SOD1 ALS program does not impact Voyager’s other gene therapy programs; the Company continues to expect IND filings in 2025 from Neurocrine Biosciences …